Home › Free Stock Grades › MGTX
MeiraGTx Holdings plc (MGTX) Stock Grade
MGTX · Healthcare
C
Market Cap
$1.0B
P/E Ratio
18.1
Revenue Growth (YoY)
+144.6%
Net Margin
-140.3%
Return on Equity
1971.4%
Dividend Yield
None
About MeiraGTx Holdings plc's fundamentals
MeiraGTx is a biotechnology company with a $1.0 billion market capitalization that has demonstrated exceptional revenue growth of 144.6% year-over-year, indicating strong commercial traction. However, the company is currently unprofitable with a net margin of -140.3% and reported a net loss in its latest annual statement, which is typical for early-stage biotech firms investing heavily in development and commercialization. The company does not pay a dividend, with capital instead directed toward operations and growth initiatives.